• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-15a增强顺铂对耐药非小细胞肺癌细胞的抗癌作用。

miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells.

作者信息

Bozok Çetintaş Vildan, Tetik Vardarlı Aslı, Düzgün Zekeriya, Tezcanlı Kaymaz Burçin, Açıkgöz Eda, Aktuğ Hüseyin, Kosova Can Buket, Gündüz Cumhur, Eroğlu Zuhal

机构信息

Department of Medical Biology, Ege University School of Medicine, Izmir, Turkey.

Department of Embryology and Histology, Ege University School of Medicine, Izmir, Turkey.

出版信息

Tumour Biol. 2016 Feb;37(2):1739-51. doi: 10.1007/s13277-015-3950-9. Epub 2015 Aug 28.

DOI:10.1007/s13277-015-3950-9
PMID:26314859
Abstract

Platinum-based chemotherapies have long been used as a standard treatment in non-small cell lung cancer. However, cisplatin resistance is a major problem that restricts the use of cisplatin. Deregulated cell death mechanisms including apoptosis and autophagy could be responsible for the development of cisplatin resistance and miRNAs are the key regulators of these mechanisms. We aimed to analyse the effects of selected miRNAs in the development of cisplatin resistance and found that hsa-miR-15a-3p was one of the most significantly downregulated miRNAs conferring resistance to cisplatin in Calu1 epidermoid lung carcinoma cells. Only hsa-miR-15a-3p mimic transfection did not affect cell proliferation or cell death, though decreased cell viability was found when combined with cisplatin. We found that induced expression of hsa-miR-15a-3p via mimic transfection sensitised cisplatin-resistant cells to apoptosis and autophagy. Our results demonstrated that the apoptosis- and autophagy-inducing effects of hsa-miR-15a-3p might be due to suppression of BCL2, which exhibits a major connection with cell death mechanisms. This study provides new insights into the mechanism of cisplatin resistance due to silencing of the tumour suppressor hsa-miR-15a-3p and its possible contribution to apoptosis, autophagy and cisplatin resistance, which are the devil's triangle in determining cancer cell fate.

摘要

铂类化疗长期以来一直被用作非小细胞肺癌的标准治疗方法。然而,顺铂耐药是限制顺铂使用的一个主要问题。包括凋亡和自噬在内的细胞死亡机制失调可能是顺铂耐药产生的原因,而微小RNA(miRNAs)是这些机制的关键调节因子。我们旨在分析特定miRNAs在顺铂耐药形成中的作用,发现hsa-miR-15a-3p是Calu1肺表皮样癌细胞中对顺铂耐药最显著下调的miRNAs之一。单独转染hsa-miR-15a-3p模拟物不影响细胞增殖或细胞死亡,不过与顺铂联合使用时细胞活力会降低。我们发现通过模拟物转染诱导hsa-miR-15a-3p表达可使顺铂耐药细胞对凋亡和自噬敏感。我们的结果表明,hsa-miR-15a-3p的凋亡诱导和自噬诱导作用可能是由于抑制了BCL2,而BCL2与细胞死亡机制有主要联系。本研究为肿瘤抑制因子hsa-miR-15a-3p沉默导致顺铂耐药的机制及其对凋亡、自噬和顺铂耐药的可能作用提供了新的见解,而凋亡、自噬和顺铂耐药是决定癌细胞命运的“魔鬼三角”。

相似文献

1
miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells.微小RNA-15a增强顺铂对耐药非小细胞肺癌细胞的抗癌作用。
Tumour Biol. 2016 Feb;37(2):1739-51. doi: 10.1007/s13277-015-3950-9. Epub 2015 Aug 28.
2
Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.抑制微小RNA-196a可能会逆转A549/DDP非小细胞肺癌细胞系的顺铂耐药性。
Tumour Biol. 2016 Feb;37(2):2387-94. doi: 10.1007/s13277-015-4017-7. Epub 2015 Sep 16.
3
Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.Mir-24-3p下调通过靶向自噬相关蛋白4A(ATG4A)导致小细胞肺癌对依托泊苷和顺铂(VP16-DDP)耐药。
Oncotarget. 2015 Jan 1;6(1):317-31. doi: 10.18632/oncotarget.2787.
4
miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.miR-503 通过靶向 Bcl-2 调节非小细胞肺癌细胞对顺铂的耐药性。
Int J Mol Med. 2013 Sep;32(3):593-8. doi: 10.3892/ijmm.2013.1439. Epub 2013 Jul 12.
5
microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.microRNA-381 通过抑制核因子-κB 信号通路抑制非小细胞肺癌细胞的生长并增加顺铂敏感性。
Biomed Pharmacother. 2018 Feb;98:538-544. doi: 10.1016/j.biopha.2017.12.092. Epub 2017 Dec 27.
6
Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC).miR-101-3p 的上调通过调节小干扰 RNA (siRNA) Anti-human AGT4D 和自噬增强非小细胞肺癌 (NSCLC) 对顺铂的敏感性。
Bioengineered. 2021 Dec;12(1):8435-8446. doi: 10.1080/21655979.2021.1982274.
7
The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.miR-17-5p、miR-92a和let-7b表达与非小细胞肺癌靶向耐药性之间的关系
J BUON. 2017 Mar-Apr;22(2):454-461.
8
A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).环状 RNA hsa_circRNA_103809/miR-377-3p/GOT1 通路调控非小细胞肺癌(NSCLC)顺铂耐药。
BMC Cancer. 2020 Dec 4;20(1):1190. doi: 10.1186/s12885-020-07680-w.
9
miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.miR-148b 通过负向调控 DNA(胞嘧啶-5)-甲基转移酶 1(DNMT1)的表达逆转非小细胞癌细胞的顺铂耐药性。
J Transl Med. 2015 Apr 28;13:132. doi: 10.1186/s12967-015-0488-y.
10
Attenuation of deregulated miR-369-3p expression sensitizes non-small cell lung cancer cells to cisplatin via modulation of the nucleotide sugar transporter SLC35F5.失调的miR-369-3p表达的减弱通过调节核苷酸糖转运蛋白SLC35F5使非小细胞肺癌细胞对顺铂敏感。
Biochem Biophys Res Commun. 2017 Jul 1;488(3):501-508. doi: 10.1016/j.bbrc.2017.05.075. Epub 2017 May 13.

引用本文的文献

1
Differential regulation of STING expression and cisplatin sensitivity by autophagy in non-small cell lung cancer cells.自噬对非小细胞肺癌细胞中STING表达及顺铂敏感性的差异调控
Med Oncol. 2025 May 30;42(7):227. doi: 10.1007/s12032-025-02786-2.
2
The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.G蛋白偶联受体GPR89A是克服非小细胞肺癌Calu1细胞顺铂耐药性的一种新型潜在治疗靶点。
FEBS J. 2025 Jul;292(14):3755-3770. doi: 10.1111/febs.70099. Epub 2025 Apr 17.
3
MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells.

本文引用的文献

1
The emerging role of microRNAs in resistance to lung cancer treatments.微小 RNA 在肺癌治疗耐药中的新兴作用。
Cancer Treat Rev. 2015 Feb;41(2):160-9. doi: 10.1016/j.ctrv.2014.12.009. Epub 2014 Dec 23.
2
miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway.微小RNA-15a/16通过靶向Toll样受体1/核因子κB信号通路增强非小细胞肺癌细胞的辐射敏感性。
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):73-81. doi: 10.1016/j.ijrobp.2014.09.021. Epub 2014 Oct 27.
3
Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells.
微小RNA作为肿瘤细胞自噬介导的顺铂反应的关键调节因子。
Cancer Cell Int. 2023 Apr 25;23(1):80. doi: 10.1186/s12935-023-02925-7.
4
Insight into autophagy in platinum resistance of cancer.对癌症铂耐药性中自噬作用的深入了解。
Int J Clin Oncol. 2023 Mar;28(3):354-362. doi: 10.1007/s10147-023-02301-5. Epub 2023 Jan 27.
5
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.细胞周期相关的微小RNA作为肺癌治疗的靶点和疗法
Heliyon. 2022 Oct 13;8(10):e11081. doi: 10.1016/j.heliyon.2022.e11081. eCollection 2022 Oct.
6
MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.MicroRNAs 作为预测肺癌对顺铂耐药和敏感的标志物。
Int J Mol Sci. 2022 Jul 8;23(14):7594. doi: 10.3390/ijms23147594.
7
Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E.miR-15a-5p 通过靶向 eIF4E 抑制促进肝癌对吡柔比星的化疗耐药性。
Comput Math Methods Med. 2021 Nov 13;2021:6468405. doi: 10.1155/2021/6468405. eCollection 2021.
8
Circular RNA SLC26A4 regulates the maturation of microRNA-15a in non-small cell lung cancer cells.环状RNA SLC26A4调控非小细胞肺癌细胞中微小RNA-15a的成熟。
Oncol Lett. 2021 Oct;22(4):722. doi: 10.3892/ol.2021.12983. Epub 2021 Aug 10.
9
A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression the miR-15a/CCNE2 Axis.一种新型雄激素诱导的长链非编码RNA FAM83H-AS1通过miR-15a/CCNE2轴促进前列腺癌进展
Front Oncol. 2021 Feb 4;10:620306. doi: 10.3389/fonc.2020.620306. eCollection 2020.
10
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy.非小细胞肺癌治疗中的血清与糖皮质激素诱导激酶1(SGK1)
Pharmaceuticals (Basel). 2020 Nov 22;13(11):413. doi: 10.3390/ph13110413.
编码miR-15a/16-1的重组慢病毒载体对人鼻咽癌CNE-2Z细胞生物学特性的影响
Cancer Biother Radiopharm. 2014 Dec;29(10):422-7. doi: 10.1089/cbr.2013.1596.
4
Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.微小RNA在非小细胞肺癌中的表达及其与临床病理特征的关联。
Tumour Biol. 2015 Mar;36(3):1603-12. doi: 10.1007/s13277-014-2755-6. Epub 2014 Nov 11.
5
Roscovitine-treated HeLa cells finalize autophagy later than apoptosis by downregulating Bcl‑2.经罗司维汀处理的HeLa细胞通过下调Bcl-2使自噬比凋亡更晚完成。
Mol Med Rep. 2015 Mar;11(3):1968-74. doi: 10.3892/mmr.2014.2902. Epub 2014 Nov 7.
6
MicroRNAs in lung cancer.肺癌中的微小RNA
World J Methodol. 2014 Jun 26;4(2):59-72. doi: 10.5662/wjm.v4.i2.59.
7
Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.自噬的诱导有助于人类卵巢癌细胞对顺铂产生耐药性。
Mol Med Rep. 2015 Jan;11(1):91-8. doi: 10.3892/mmr.2014.2671. Epub 2014 Oct 16.
8
Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.诱导自噬可拮抗获得性耐药的人食管癌细胞中顺铂的抗癌作用。
Cancer Lett. 2014 Dec 1;355(1):34-45. doi: 10.1016/j.canlet.2014.09.020. Epub 2014 Sep 16.
9
Cisplatin in cancer therapy: molecular mechanisms of action.顺铂在癌症治疗中的作用:分子作用机制
Eur J Pharmacol. 2014 Oct 5;740:364-78. doi: 10.1016/j.ejphar.2014.07.025. Epub 2014 Jul 21.
10
Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.13q14处MIR15A和MIR16 - 1的缺失与慢性淋巴细胞白血病中TP53 mRNA增加、BCL2去抑制及不良预后相关。
Br J Haematol. 2014 Nov;167(3):346-55. doi: 10.1111/bjh.13043. Epub 2014 Jul 18.